$800 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 67 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | New | APELLIS PHARMACEUTIC | $38,033,000 | – | 1,752,655 | +100.0% | 4.75% | – |
| ABT | New | ABBOTT LABS | $21,853,000 | – | 382,909 | +100.0% | 2.73% | – |
| LLY | New | ELI LILLY & CO | $13,868,000 | – | 164,200 | +100.0% | 1.73% | – |
| VRAY | New | VIEWRAY INC | $8,772,000 | – | 947,306 | +100.0% | 1.10% | – |
| ABBV | New | ABBVIE INC | $8,249,000 | – | 85,298 | +100.0% | 1.03% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $7,036,000 | – | 117,815 | +100.0% | 0.88% | – |
| PODD | New | INSULET CORP | $6,521,000 | – | 94,509 | +100.0% | 0.82% | – |
| HRC | New | HILL-ROM HLDS INC | $5,854,000 | – | 69,450 | +100.0% | 0.73% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS | $3,382,000 | – | 36,850 | +100.0% | 0.42% | – |
| SAGE | New | SAGE THERAPEUTICS | $2,833,000 | – | 17,200 | +100.0% | 0.35% | – |
| SVRA | New | SAVARA INC | $2,374,000 | – | 160,000 | +100.0% | 0.30% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS | $1,749,000 | – | 300,000 | +100.0% | 0.22% | – |
| ESPR | New | ESPERION THERAPEUTICS | $1,536,000 | – | 23,333 | +100.0% | 0.19% | – |
| PBYI | New | PUMA BIOTECHNOLOGY | $1,488,000 | – | 15,050 | +100.0% | 0.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.